Avanos Medical Inc (AVNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -392,100 | 5,200 | 900 | -900 | -61,800 |
| Depreciation Amortization | 482,200 | 34,400 | 22,700 | 11,400 | 46,100 |
| Income taxes - deferred | -39,400 | 2,800 | 2,200 | -400 | -22,400 |
| Accounts receivable | -6,600 | -6,900 | 800 | 8,200 | 39,000 |
| Accounts payable and accrued liabilities | -900 | -1,200 | 0 | 2,300 | -14,400 |
| Other Working Capital | 35,000 | -10,000 | -13,700 | -22,000 | -18,000 |
| Other Operating Activity | 22,500 | 18,500 | 6,900 | -6,600 | 63,900 |
| Operating Cash Flow | $100,700 | $42,800 | $19,800 | $-8,000 | $32,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17,800 | -13,000 | -10,000 | -4,100 | -17,800 |
| Net Acquisitions | 2,100 | 2,100 | 2,100 | 2,100 | 39,400 |
| Other Investing Activity | -11,800 | -9,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-27,500 | $-19,900 | $-7,900 | $-2,000 | $21,600 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,000 | 20,000 | 20,000 | 20,000 | 55,000 |
| Debt Repayment | -53,600 | -26,300 | -13,100 | -11,600 | -119,700 |
| Common Stock Issued | 1,100 | 1,100 | 500 | 500 | 1,300 |
| Common Stock Repurchased | -12,800 | -12,700 | -12,600 | -9,100 | -19,100 |
| Other Financing Activity | -3,800 | -3,800 | -500 | -500 | -11,700 |
| Financing Cash Flow | $-49,100 | $-21,700 | $-5,700 | $-700 | $-94,200 |
| Exchange Rate Effect | -4,100 | 100 | -1,700 | -1,200 | 200 |
| Beginning Cash Position | 87,700 | 87,700 | 87,700 | 87,700 | 127,700 |
| End Cash Position | 107,700 | 89,000 | 92,200 | 75,800 | 87,700 |
| Net Cash Flow | $20,000 | $1,300 | $4,500 | $-11,900 | $-40,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 100,700 | 42,800 | 19,800 | -8,000 | 32,400 |
| Capital Expenditure | -17,800 | -13,000 | -10,000 | -4,100 | -17,800 |
| Free Cash Flow | 82,900 | 29,800 | 9,800 | -12,100 | 14,600 |